InvestorsHub Logo
Followers 62
Posts 7567
Boards Moderated 1
Alias Born 01/02/2003

Re: HDGabor post# 275995

Sunday, 05/24/2020 12:59:55 PM

Sunday, May 24, 2020 12:59:55 PM

Post# of 426643
HDG...QUOTE "Omacor??!!! Gees … How about Epanova?
A long-time Amarin poster has no clue about competitors"

Amarin... Vascepa...purified EPA from esterified Omega3's
AZN...Omacor...omega3's...EPA plus DHA
AZN... Epanova...omega3's...EPA plus DHA
AZN...Lovaza...omega3's EPA plus DHA

Lovaza has been approved by the FDA for patients with >500gms/dcl to reduce incidence of pancreatitis...but not approved to reduce incidence of CVD...It is being used in the U.S.

Omacor was bought by AZN and is not being used in the U.S. at this time

Epanova failed the Strength test and is not being used in the U.S.


Vascepa is being used in the U.S....At this time, its main competition is Lovaza, but Generic versions of Vascepa are waiting in the wings.The major issue, which Vascepa has faced since its inception... is its being confused with "fish oil"...sometimes by mistake...sometimes intentional.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News